No Data
The U.S. bioterrorism law has undergone significant changes, the CRO concept has launched a major counterattack, and WuXi AppTec is excited!
Industry pessimistic expectations may improve.
How to break through the challenges in the development of innovative drugs? The industry suggests focusing on internationalization.
① The year 2024 will be the inaugural year of large-scale authorized trade, and going abroad has become an important direction for the development of local pharmaceutical companies; ② Chinese企业品牌, clinical trial capabilities, data presentation formats, and levels of international operation still need time and practical verification.
Adidas Consortium-B (02197) SCB-1019: The potential best in its class, reshaping the global RSV market landscape
With its unique Trimer-Tag technology platform, Clover Biopharmaceuticals' RSV candidate vaccine SCB-1019 is expected to be a potential best-in-class, reshaping the market landscape of RSV vaccines~
Hong Kong healthcare stocks receive attention from investors again, with Trifolium Biotech surging nearly 15%.
①What is the impact of medical insurance negotiations on pharmaceutical stocks? ②What are the reasons for the rise of Tri Clover Biopharmaceutical and Yimington Corporation?
Hong Kong Stock Market News | Clover Biopharmaceuticals-B (02197) surged more than 14%, positive results from Phase I study of bivalent RSV vaccine.
Adidas AG (02197) rose over 14%, as of the time of publication, up 14.75% to 0.35 Hong Kong dollars, with a turnover of 0.8356 million Hong Kong dollars.
Express News | Clover Announces Positive Clinical Data for Rsv Vaccine Candidate Scb-1019 Compared Head-to-Head Versus GSK's Arexvy
Unlock the Full List
